Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net sales	$ 21,533	$ 23,375	$ 20,453
Cost of sales	16,954	19,403	16,628
Gross profit	4,579	3,972	3,825
Operating expenses:
Research and development	597	368	(515)
Sales and marketing	4,899	4,402	4,828
General and administrative	4,815	4,542	5,006
Loss on impairment	933	672
Valuation of equity instruments			56
Change in estimate of contingent liabilities	12	(102)	(411)
Restructuring	80
Total operating expenses	11,336	9,882	8,964
Loss from operations	(6,757)	(5,910)	(5,139)
Other income (expense):
Settlement of acquisition obligations	892		(56)
Interest income		2	4
Interest expense	(842)	(511)	(861)
Other (expense) income	(240)	(157)	21
Loss from continuing operations before income taxes	(6,947)	(6,576)	(5,975)
Benefit from income taxes			2
Net loss from continuing operations	(6,947)	(6,576)	(5,973)
Discontinued operations:
Income (loss) from discontinued operations	672	867	(82)
Gain on sale of discontinued operations	3,915
Income (loss) from discontinued operations before income taxes	4,587	867	(82)
Provision for income taxes	(1)
Net income (loss) from discontinued operations	4,586	867	(82)
Net loss	$ (2,361)	$ (5,709)	$ (6,055)
Basic and Diluted
From continung operations (in Dollars per share)	$ (0.15)	$ (0.16)	$ (0.25)
From discontinued operations (in Dollars per share)	$ 0.10	$ 0.02
Total (in Dollars per share)	$ (0.05)	$ (0.14)	$ (0.25)
Weighted average common shares outstanding:
Basic and Diluted (in Shares)	47,792	41,322	24,669